NCT05423353

Brief Summary

There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis. The aim of this study is performing this comparison.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

July 25, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 19, 2022

Completed
Last Updated

November 29, 2022

Status Verified

November 1, 2022

Enrollment Period

1 month

First QC Date

June 14, 2022

Last Update Submit

November 28, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    at baseline (before the treatment)

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    2 weeks after baseline (at the end of treatment)

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    6 weeks after baseline (one month after the end of treatment)

  • Duruöz Hand Index (DHI)

    Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.

    at baseline (before the treatment)

  • Duruöz Hand Index (DHI)

    Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.

    2 weeks after baseline (at the end of treatment)

  • Duruöz Hand Index (DHI)

    Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.

    6 weeks after baseline (one month after the end of treatment)

Study Arms (2)

Paraffin Bath Therapy

ACTIVE COMPARATOR

Paraffin bath therapy is a physical therapy method that can create a temperature increase of 7.5 °C in the joint capsule and 4.5 °C in the muscle.

Device: Paraffin Bath Therapy

Extracorporeal Shock Wave Therapy

ACTIVE COMPARATOR

Extracorporeal shock wave therapy (ESWT) is a noninvasive treatment that involves delivery of shock waves to injured soft tissue to reduce pain and promote healing.

Device: Extracorporeal Shock Wave Therapy

Interventions

Device named 'Fizyowax 1300' (Fizyomed, Turkey).

Paraffin Bath Therapy

Device named 'Elettronica Pagani,Italy' and will be used with radial probe.

Extracorporeal Shock Wave Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years or older
  • Meeting De Quervain diagnostic criteria
  • Not having applied any physical therapy modality to the hand-wrist in the last 1 month
  • Not using pain medication in the last 1 month,
  • Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months
  • Have received written consent to participate in the study, and have come to the last control at the 6th week.

You may not qualify if:

  • Neurological diseases (especially neuropathies),
  • Malignancy,
  • Rheumatological diseases
  • Pregnancy
  • History of hand/wrist fracture or surgery
  • Hand/wrist trauma in the last 1 month
  • Coagulation disorder diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuzuncu Yil University

Van, Turkey (Türkiye)

Location

MeSH Terms

Conditions

De Quervain Disease

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Tendon EntrapmentTendinopathyMuscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Volkan Şah

    Yüzüncü Yıl Üniversitesi Tıp Fakültesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 14, 2022

First Posted

June 21, 2022

Study Start

July 25, 2022

Primary Completion

September 5, 2022

Study Completion

October 19, 2022

Last Updated

November 29, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations